| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |